| Literature DB >> 26000291 |
Yu-Jiao Guo1, De-Wang Wang1, Ling Meng1, Yong-Qing Wang1.
Abstract
Several reports describing anaphylactic shock following treatment of cardiovascular and cerebrovascular diseases with Chinese herbal injections were described. Our analysis of these reports showed that anaphylactic shock caused by traditional Chinese medicine (TCM) injections for the treatment of cardiovascular and cerebrovascular diseases is common but also sometimes fatal. Therefore, we proposed the following four suggestions for improving the clinical safety of delivering Chinese herbal injections and reducing the occurrence of allergic shock. First, patients with cardiovascular and cerebrovascular diseases are at high risk, so they should only be given TCM injections after a doctor's diagnosis and approval. Second, people in allergic groups can suffer anaphylactic shock, so vigilance is important in the treatment of all age groups, although even more caution should be exercised when treating children or elderly people. In fact, TCM injections may not be appropriate for those age groups, so that they should be carefully considered before treatment. Third, no significant gender differences have been noted in patients with anaphylactic shock, so all patients should be carefully monitored, irrespective of gender. Fourth, the timeframe in which different drugs cause anaphylactic shock varies; thus, patients should be observed as long as possible.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26000291 PMCID: PMC4426654 DOI: 10.1155/2015/420607
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Patients who suffered anaphylactic shock after being treated with 17 types of traditional Chinese medicine injections for cardiovascular and cerebrovascular diseases.
| Serial number | Chinese herbal injections | Constituents | Number of cases | Distributions of ages* | Sex | Mode of delivery | Onset of symptoms | Distributions of onset* | Timely rescue | Number of deaths |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Shenmai injection | (1) Red ginseng | 39 | 0/22/11/6 | 26 F, 13 M | 36IVI*, 3IMI* | 10 s–1 h | 8/25/6/0/0 | Yes | 0 |
|
| ||||||||||
| 2 | Ciwujia injection | Ciwujia stem and leaf extracts | 33 | 0/11/14/8 | 15 F, 18 M | 33IVI | 3 min–2.5 h | 1/15/13/3/1 | Yes | 0 |
|
| ||||||||||
| 3 | Salvia miltiorrhiza injection |
| 9 | 0/5/2/2 | 3 F, 6 M | 9IVI | 1 min–30 min | 2/4/3/0/0 | Yes | 0 |
|
| ||||||||||
| 4 | Tanshinone IIA sodium |
| 5 | 0/0/1/4 | 3 F, 2 M | 5IVI | 2 min–30 min | 0/1/4/0/0 | Yes | 0 |
|
| ||||||||||
| 5 | Dan Hong injection | (1) | 4 | 0/2/0/2 | 3 F, 1 M | 4IVI | 1 min–40 min | 0/3/1/0/0 | Yes | 0 |
|
| ||||||||||
| 6 | Breviscapine injection |
| 11 | 0/2/4/5 | 3 F, 8 M | 11IVI | 3 min–2 h | 0/2/6/3/0 | Yes | 0 |
|
| ||||||||||
| 7 | Erigeron injection |
| 6 | 0/0/0/6 | 4 F, 2 M | 6IVI | 10 min–1.5 h | 0/1/4/1/0 | Yes | 0 |
|
| ||||||||||
| 8 | Compound Danshen injection | (1) | 53 | 0/19/18/16 | 23 F, 30 M | 53IVI | 10 s–2 h | 5/30/15/3/0 | Yes | 5 death, 1 fetal death |
|
| ||||||||||
| 9 | Puerarin injection | (1) Puerarin extract | 23 | 0/1/11/11 | 8 F, 15 M | 23IVI | 2 min–2 h | 1/2/18/2/0 | Yes | 2 |
|
| ||||||||||
| 10 | Safflower injection | Safflower extract | 27 | 0/7/10/11 | 15 F, 12 M | 27IVI | 2 min–1 h | 1/16/10/0/0 | Yes | 0 |
|
| ||||||||||
| 11 | Mailuoning injection | Honeysuckle, | 64 | 1/19/15/29 | 30 F, 34 M | 64IVI | 10 s–50 min | 11/40/13/0/0 | Yes | 2 |
|
| ||||||||||
| 12 | Shengmai injection | Red ginseng, | 16 | 0/2/5/9 | 7 F, 9 M | 16IVI | 10 s–30 min | 3/10/3/0/0 | Yes | 0 |
|
| ||||||||||
| 13 | Shuxuetong injection | Leech and earthworm | 6 | 0/1/3/2 | 4 F, 2 M | 6IVI | 5 min–1.5 h | 0/3/2/1/0 | Yes | 0 |
|
| ||||||||||
| 14 | Xingnaojing injection | Musk, borneol, turmeric, | 17 | 2/7/3/5 | 4 F, 13 M | 17IVI | 3 s–45 min | 1/12/4/0/0 | Yes | 0 |
|
| ||||||||||
| 15 | Xuebijing injection | Extracts: safflower, Radix Paeoniae Rubra, Rhizoma Chuanxiong, Radix | 12 | 2/7/2/1 | 7 F, 5 M | 12IVI | 2 min–10 min | 0/12/0/0/0 | Yes | 0 |
|
| ||||||||||
| 16 | Xuesaitong injection | Total saponins of three-seven byproducts, main components: Ginsenoside Rb1, Ginsenoside Rg1, three-seven, Ginsenoside R1 | 21 | 0/3/5/13 | 13 F, 8 M | 20IVI, 1IMI | 2 min–1.5 h | 1/11/8/1/0 | Yes | 0 |
|
| ||||||||||
| 17 | Xueshuantong injection | Three-seven root extracts, main components: Ginsenoside Rg1, Ginsenoside Rb1 | 4 | 0/0/2/2 | 1 F, 3 M | 4IVI | 3 min–1 h | 0/2/2/0/0 | Yes | 0 |
|
| ||||||||||
| Total | 350 | 5/108/106/132 | 169 F, 181 M | 34/189/112/14/1 | ||||||
*Distributions of ages: number of children (≤18 years)/number of youth (19–45 years)/number of middle-aged (46–59 years)/number of aged cases (≥60 years).
*Distributions of onset: within 1 min/between 1 min to 10 mins/between 11 mins to 60 mins/between 61 mins to 120 mins/over 120 mins.
IVI: intravenous injection.
IMI: intramuscular injection.
The references of the cases are in the support material.